for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Blackstone Group Inc

BX.N

Latest Trade

53.73USD

Change

0.36(+0.67%)

Volume

379,736

Today's Range

52.97

 - 

53.80

52 Week Range

33.00

 - 

64.97

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
53.37
Open
53.59
Volume
379,736
3M AVG Volume
89.95
Today's High
53.80
Today's Low
52.97
52 Week High
64.97
52 Week Low
33.00
Shares Out (MIL)
669.88
Market Cap (MIL)
64,722.18
Forward P/E
26.42
Dividend (Yield %)
3.62

Next Event

Q2 2020 Blackstone Group Inc Earnings Release

Latest Developments

More

Hudson Pacific Properties, Blackstone Report New Joint Venture

Blackstone Signed Venture With HPP For Film-Production Facilities - WSJ

London Stock Exchange says committed to closing Refinitiv deal in 2020

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Blackstone Group Inc

Blackstone Group Inc., formerly The Blackstone Group L.P., is an alternative asset manager. The Company's alternative asset management businesses include investment vehicles focused on private equity, non-investment grade credit, secondary private equity funds of funds and multi-asset class strategies. It operates through four segments: Private Equity, Real Estate, Hedge Fund Solutions and Credit. The Private Equity segment includes its corporate private equity business, which consists of its corporate private equity funds, Blackstone Capital Partners funds, its sector-focused corporate private equity funds, including its energy-focused funds, Blackstone Energy Partners funds and its core private equity fund. The Blackstone Real Estate Partners funds target a range of opportunistic real estate and real estate related investments. The Hedge Fund Solutions segment consists of Blackstone Alternative Asset Management. The Credit segment consists principally of GSO Capital Partners LP.

Industry

Investment Services

Contact Info

345 Park Ave

NEW YORK, NY

10154-0004

United States

+1.212.5835000

https://www.blackstone.com/

Executive Leadership

Stephen A. Schwarzman

Chairman of the Board, Chief Executive Officer, Founder

Jonathan D. Gray

President, Chief Operating Officer, Director of the General Partner

Hamilton E. James

Executive Vice Chairman of the Board

Michael S. Chae

Chief Financial Officer of the General Partner

John Stecher

Chief Technology Officer

Key Stats

2.17 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

6.8K

2018

6.8K

2019

5.6K

2020(E)

5.3K
EPS (USD)

2017

2.810

2018

2.360

2019

2.310

2020(E)

2.057
Price To Earnings (TTM)
73.59
Price To Sales (TTM)
28.93
Price To Book (MRQ)
6.84
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
194.96
LT Debt To Equity (MRQ)
193.01
Return on Investment (TTM)
1.15
Return on Equity (TTM)
0.65

Latest News

Latest News

UPDATE 1-Blackstone eyes US$7.5bn for mezzanine debt

Private equity firm Blackstone Group LP's credit arm GSO Capital Partners is seeking US$7.5bn for its fourth subordinated debt vehicle, according to investor notes from the Teachers’ Retirement System of Louisiana.

REFILE-Blackstone eyes US$7.5bn for mezzanine debt

Private equity firm Blackstone Group LP's credit arm GSO Capital Partners is seeking US$7.5bn for its fourth subordinated debt vehicle, according to investor notes from the Teachers’ Retirement System of Louisiana.

Blackstone adds Alphabet CFO Ruth Porat to its board

Blackstone Group Inc <BX.N> said on Thursday Alphabet Inc's <GOOGL.O> finance chief, Ruth Porat, will join the private equity firm's board of directors.

Blackstone adds Alphabet CFO Ruth Porat to its board

Blackstone Group Inc said on Thursday Alphabet Inc's finance chief, Ruth Porat, will join the private equity firm's board of directors. (Reporting by C Nivedita; Editing by Vinay Dwivedi)

Exclusive: Blackstone, Taisho Pharma among final bidders for Takeda's Japan OTC unit - sources

Blackstone, Bain Capital and Taisho Pharmaceutical are among the final bidders for Takeda Pharmaceutical's consumer drug business in Japan, a deal that could be worth up to 400 billion yen ($3.7 billion), three people familiar with the deal said.

BRIEF-Reata Pharmaceuticals & Blackstone Life Sciences Announce $350 Million Strategic Investment

* REATA PHARMACEUTICALS, INC. AND BLACKSTONE LIFE SCIENCES ANNOUNCE $350 MILLION STRATEGIC INVESTMENT

Breakingviews - Corona Capital: U.S. recession, Grubhub, Airlines

Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

UPDATE 2-Italy's RCS says court ruled 2013 sale to Blackstone valid, may still win damages

Milan's Arbitral Tribunal has judged that the 2013 sale of RCS' headquarters to Blackstone Group was valid but found that the purchaser's behaviour may entitle the Italian publisher to compensatory damages, RCS said late on Tuesday.

Blackstone risks paying damages in dispute with Italy's RCS

Milan's Arbitral Tribunal has judged that the contracts over the sale of Italy's RCS headquarters to Blackstone in 2013 were valid but found that the purchaser's behaviour may entitle the Italian publisher to compensatory damages, RCS said on Tuesday.

NIBC says it will pay 2019 dividend to Blackstone to ensure acquisition

Dutch bank NIBC Holding NV <NIBC.AS> said late on Monday it has agreed to pay its 2019 dividend to its proposed buyer, U.S. equity firm Blackstone Group Inc <BX.N>, before the deal settles, in order to remove one hurdle to the proposed 1.36 billion-euro ($1.47 billion) takeover...

Blackstone shale oil venture Gavilan Resources files for bankruptcy

Blackstone Group's <BX.N> Gavilan Resources LLC filed for Chapter 11 bankruptcy late on Friday, citing this year's oil price collapse and a bitter legal battle with a partner.

Blackstone takes $360 million stake in Australia's Crown, stoking buyout hope

Private equity company Blackstone Group Inc bought a near 10% stake in Australian casino operator Crown Resorts Ltd from Macau's Melco Resorts & Entertainment Ltd, sending Crown shares soaring amid hopes of a buyout.

Australia's Crown Resorts says Blackstone bought near 10% of its shares

Australia's Crown Resorts Ltd said on Wednesday that U.S. private equity firm Blackstone Group Inc had bought some of its shares from Macau casino operator Melco Resorts & Entertainment Ltd.

Blackstone says coronavirus crisis could derail NIBC deal

Private equity firm Blackstone <BX.N> said on Tuesday its proposed 1.36 billion euro ($1.47 billion) takeover of NIBC Holding NV <NIBC.AS> might not win regulatory approval, sending shares in the Dutch bank 12% lower.

Blackstone says NIBC deal uncertain without dividend payout

Private equity firm Blackstone said on Tuesday it would not be able to finance its proposed 1.36 billion euro ($1.47 billion) takeover of NIBC Holding NV if the Dutch bank continues to withhold its dividend over 2019.

Blackstone's first-quarter profit rises but coronavirus weighs

Blackstone Group Inc, the world's largest manager of alternative assets such as private equity and real estate, reported a 4% rise in first-quarter distributable earnings on Thursday, driven by a surge in management fees, even as its funds took a hit in the coronavirus-induced...

Blackstone's first-quarter profit rises but coronavirus weighs

Blackstone Group Inc, the world's largest manager of alternative assets such as private equity and real estate, reported a 4% rise in its first-quarter distributable earnings driven by a surge in management fees on strong fundraising, even as its funds took a hit in the...

Tallgrass shareholders approve Blackstone-led buyout of pipeline operator

Tallgrass Energy <TGE.N> shareholders on Thursday backed a buyout by a Blackstone-led <BX.N> group that valued the U.S. oil pipeline operator at $6.3 billion, a rare case of a pre-market crash deal going ahead without a price cut.

Alnylam's gene-silencing efforts get $2 billion Blackstone backing

Blackstone Group Inc said on Monday it would invest $2 billion in Alnylam Pharmaceuticals Inc through an equity-and-debt deal, giving the drugmaker a financial boost without tapping into currently volatile stock markets for funds.

Blackstone invests $2 bln in Alnylam Pharma

Blackstone Group Inc said on Monday it invested $2 billion in Alnylam Pharmaceuticals Inc through an equity-and-debt deal, giving the drugmaker a financial boost to develop its experimental therapies.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up